1-225921246-C-CAG

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong

The NM_013328.4(PYCR2):​c.757_758dupCT​(p.Leu254CysfsTer35) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

PYCR2
NM_013328.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 6.27
Variant links:
Genes affected
PYCR2 (HGNC:30262): (pyrroline-5-carboxylate reductase 2) This gene belongs to the pyrroline-5-carboxylate reductase family. The encoded mitochondrial protein catalyzes the conversion of pyrroline-5-carboxylate to proline, which is the last step in proline biosynthesis. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Nov 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-225921246-C-CAG is Pathogenic according to our data. Variant chr1-225921246-C-CAG is described in ClinVar as [Likely_pathogenic]. Clinvar id is 286401.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PYCR2NM_013328.4 linkc.757_758dupCT p.Leu254CysfsTer35 frameshift_variant Exon 6 of 7 ENST00000343818.11 NP_037460.2 Q96C36A0A0S2Z5U6
PYCR2NM_001271681.2 linkc.535_536dupCT p.Leu180CysfsTer35 frameshift_variant Exon 5 of 6 NP_001258610.1 Q96C36A0A087WTV6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PYCR2ENST00000343818.11 linkc.757_758dupCT p.Leu254CysfsTer35 frameshift_variant Exon 6 of 7 1 NM_013328.4 ENSP00000342502.6 Q96C36
ENSG00000255835ENST00000432920.2 linkc.535_536dupCT p.Leu180CysfsTer297 frameshift_variant Exon 5 of 8 2 ENSP00000414068.2 J3KR12

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Jul 26, 2023
GeneDx
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Frameshift variant predicted to result in protein truncation, as the last 67 amino acids are replaced with 34 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge -

Mar 07, 2016
Eurofins Ntd Llc (ga)
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 13, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant disrupts a region of the PYCR2 protein in which other variant(s) (p.Arg266*) have been determined to be pathogenic (PMID: 27130255, 27860360, 30369941, 31487502). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This sequence change creates a premature translational stop signal (p.Leu254Cysfs*35) in the PYCR2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 67 amino acid(s) of the PYCR2 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PYCR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 286401). For these reasons, this variant has been classified as Pathogenic. -

Hypomyelinating leukodystrophy 10 Pathogenic:1
Nov 13, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: PYCR2 c.757_758dupCT (p.Leu254CysfsX35) results in a premature termination codon, predicted to cause a truncation of the encoded protein. Although nonsense mediated decay is not expected, this variant affects a region where other pathogenic variant(s) have been observed in ClinVar. The variant was absent in 251136 control chromosomes. To our knowledge, no occurrence of c.757_758dupCT in individuals affected with Hypomyelinating Leukodystrophy 10 and no experimental evidence demonstrating its impact on protein function have been reported. Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs886043378; hg19: chr1-226108946; API